Andrew M. Lowy, MD, FACS Appointed the Levine Family Chancellor’s Endowed Chair in Surgical Oncology
|
The Levine Family Chancellor’s Endowed Chair in Surgical Oncology was established by Peter J. Levine as part of the Chancellor’s Endowed Chair Challenge to support the recruitment and retention of outstanding tenured faculty. Andrew M. Lowy, MD, FACS, is the inaugural holder of this prestigious honor.
|
30th Annual Luau and Legends of Surfing Invitational
|
Join Moores on August 26 and 27, 2023 for a fundraiser like no other. Over its 30 year history, the Annual Luau has raised over $10 million to support novel cancer research and improve patient care. This year, an in-person sponsor party will take place on Saturday evening, followed by the Luau and Legends Invitational on Sunday morning. Tickets and volunteer opportunities still are available. Visit Website»
|
|
|
August 23, 2023 | 1:00 p.m. PT
|
August 26, 2023 | 8:30 a.m. PT
Bahia Resort Hotel, Mission Bay
|
August 30, 2023 | 1:00 p.m. PT
Goldberg Auditorium
|
September 13, 2023 | 11:30 a.m. PT
Goldberg Auditorium
|
|
|
FEATURED FUNDING OPPORTUNITIES |
The BCRP Clinical Research Extension Award aims to (1) extend or expand the data collection, follow-up, and analysis of breast cancer clinical studies and (2) increase the clinically relevant effect of breast cancer patient participation in clinical research by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. Patient contributions of tissue, serum, and other biologic specimens and their data are invaluable to saving lives. This BCRP mechanism ensures that science values those contributions with research that maximizes their effect.
Deadline: Tuesday, September 12, 2023
|
This Notice of Funding Opportunity (NOFO) invites proposals for research centers to advance cancer control equity by stimulating community-engaged, multilevel research interventions that address the impact of social determinants of health (SDOH) on adverse cancer control outcomes. Each Research Center will (1) develop interventions that target the multilevel pathways by which SDOH impact adverse cancer outcomes, (2) develop measures, methods, and assess community-level SDOH, community engagement, and cancer control equity processes and outcomes, and (3) build capacity and engagement among scholars from diverse backgrounds, those from groups underrepresented in the biomedical sciences, and community partners to implement interventions that incorporate the lived experiences of those who face cancer inequities.
Deadline: Thursday, September 14, 2023
|
Proposed research projects may address any topic related to the scientific study of prostate cancer, which include—but are not limited to—the prevention, diagnosis, treatment, or etiology of prostate cancer. The proposed research may be basic, translational, behavioral, or clinical in nature. At this time, proposals are open to only faculty researchers.
Deadline: Friday, September 15, 2023
|
Proposed research projects may address any topic related to the scientific study of prostate cancer, which include—but are not limited to—the prevention, diagnosis, treatment, or etiology of prostate cancer. The proposed research may be basic, translational, behavioral, or clinical in nature. At this time, proposals are open to only faculty researchers.
Deadline: Tuesday, October 3, 2023
|
|
|
Annals of Surgical Oncology
Joel Baumgartner (Solid Tumor Therapeutics)
|
Journal of Cancer Research and Clinical Oncology
Tarik Benmarhnia (Cancer Control Program)
|
The Journal of Experimental Medicine
Jack D. Bui (Hematologic Malignancies) and Enfu Hui (Hematologic Malignancies)
|
|
|
TWT-203: A Dose-confirming Study of CFI402257 as a Single Agent in Advanced Solid Tumors and in Combination with Fulvestrant in Patients with ER/HER2 Advanced Breast Cancer After Disease Progression on Prior CDK4/6 and Endocrine Therapy
|
ONC201-108: ONC201 for the Treatment of Newly Diagnosed H3 K27Mmutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
|
J2060: A Randomized Phase II Study Comparing Sequential High Dose Testosterone and Enzalutamide to Enzalutamide Alone in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer
|
PI: Rana McKay
NCT: NCT04363164
|
AMC 105: A Multicenter, Open-label Feasibility Study of Daratumumab with Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma
|
PI: William Wachsman
NCT: NCT04139304
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
Assembly Member Dr. Akilah Weber’s Annual Backpack Giveaway Recap
|
COE represented Moores in El Cajon on July 29 for Assembly Member Dr. Akilah Weber's Annual Backpack Giveaway. Over 1,000 backpacks were provided at the event, and over 300 individuals visited the COE table to receive cancer prevention resources, which included flyers on the cancer-preventing HPV vaccine—just in time for California HPV Vaccine Week.
|
Jackie Robinson Family YMCA Health and Resource Fair Recap
|
COE and CHEER (Center for Health Equity, Education, & Research) collaborated at the monthly Jackie Robinson Family YMCA Health and Resource Fair. COE provided cancer prevention resources to about 80 community members and will return for the next Health and Resource Fair on September 6, 2023, which will address Prostate Cancer Awareness Month.
|
Cancer Prevention 101—Border View YMCA
|
This past week, COE held its 8th "Cancer Prevention 101" workshop—the first to be held in South Bay, at the Border View YMCA. These workshops empower and educate community members on cancer prevention. Workshops address identifying risk factors, understanding essential screening guidelines, and connecting communities to available resources and Moores.
COE is excited to collaborate further with the community this fall. If you are interested in learning more about presentations or seeking assistance in planning a community event, then do not hesitate to connect with COE at MCCcoe@health.ucsd.edu.
|
Free HIV/STD Testing and Cancer Prevention Education
Tuesday, August 15 | 6:00 p.m. to 8:00 p.m.
|
COE will be tabling at the Dojo Cafe (4350 El Cajon Boulevard) on Tuesday, August 15, 2023 from 6:00 p.m. to 8:00 p.m. This special event is part of the "QT Tuesdays" series and will spotlight the importance of testing. Free HIV/STD testing and other resources will be available.
|
Prostate Cancer in the Black and African American Community: Barriers and Solutions
Tuesday, August 29 | 12:00 p.m. to 1:00 p.m.
|
African American men exhibit an increased risk for developing prostate cancer, compared to white men and other men of color. Not only will one in six Black men will develop prostate cancer in his lifetime, but Black men also are 1.7 times more likely to be diagnosed with—and 2.1 times more likely to die from—prostate cancer than white men. Moreover, Black men are more likely than white men to be diagnosed with advanced disease. Against this backdrop, please join ZERO Prostate Cancer and COE virtually on August 29, 2023 to discuss barriers and solutions to prevent, find, treat, and survive prostate cancer in the Black and African American community. Members of the community, advocates, and practitioners all are welcome.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
3855 Health Sciences Drive MC 0698 | La Jolla, CA 92093 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
|
|
|
